1. China Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Nanjing Sinolife United Co., Ltd. Class H

Nanjing Sinolife United Co., Ltd. Class H

HHKEX:3332
0.17
HKD
-0.01
(-7.78%)
170.67MMarket Cap
Nanjing Sinolife United Co., Ltd. Class H
HKEX:3332
(Hong Kong Exchange)

Recent

price

0.17

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.27
0.33
0.31
0.47
0.53
0.5
0.48
0.34
0.31
0.27
0.29
0.6
0.79
0.82
- -
Revenue per Share
0.1
0.12
0.13
0.16
0.1
- -
-0.12
-0.21
-0.05
-0.03
-0.02
0.06
0.04
0.03
- -
Basic EPS, GAAP
0.1
0.13
0.09
0.1
0.06
-0.16
-0.02
-0.09
- -
-0.01
- -
0.05
-0.01
0.07
- -
Free Cash Flow per Basic Share
0.06
0.1
- -
0.12
0.15
0.11
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.2
0.3
0.75
0.79
0.87
0.76
0.64
0.43
0.38
0.35
0.34
0.4
0.42
0.44
0.44
Book Value per Share
0.2
0.3
0.75
0.71
0.61
0.51
0.47
0.34
0.32
0.31
0.3
0.36
0.38
0.41
0.41
Tangible Book Value per Share
550
589
826
838
876
946
946
946
946
946
946
946
946
946
946
Basic Weighted Avg Shares
150
195
252
397
466
472
453
323
297
252
275
564
748
773
- -
Sales/Revenue/Turnover
50.16
47.75
51.55
43.43
24.5
7.47
-11.76
-34.24
-10.09
-12.5
-4.4
10.46
5.6
3.27
- -
Operating Margin (%)
2
3
3
7
12
11
13
23
22
19
15
14
14
13
- -
Depreciation Expense
57
71
108
136
87
4
-113
-195
-50
-32
-14
53
35
25
- -
Net Income, GAAP
25.58
25.49
22.71
24.69
24.16
23.03
- -
- -
- -
- -
- -
9.45
15.46
7.85
- -
Effective Tax Rate (%)
38.06
36.35
42.73
34.31
18.71
0.89
-24.9
-60.34
-16.73
-12.57
-5.18
9.33
4.62
3.19
- -
Profit Margin (%)
91
157
586
581
558
406
285
151
142
128
127
193
218
246
252
Working Capital
- -
- -
- -
- -
- -
28
8
13
9
5
31
31
30
28
26
LT Debt
120
184
633
716
881
715
604
411
362
330
324
378
394
417
417
Total Equity
- -
43.56
23.04
18.67
10.54
3.18
- -
- -
- -
- -
- -
13.96
8.29
4.83
- -
Return on Invested Capital (%)
- -
46.66
26.41
19.8
10.5
-0.12
- -
- -
- -
- -
- -
14.38
8.9
5.9
- -
Return on Capital (%)
- -
46.66
26.58
21.08
11.73
0.55
-17.11
-38.37
-12.83
-9.16
-4.36
14.99
8.95
6.08
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
25
79
166
LT Borrowings
- -
- -
- -
LT Finance Leases
31
28
26
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
946
946
946
Market Capitalization
402
324
148

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
333
393
493
Cash, Cash Equivalents & STI
136
182
124
Accounts Receivable, Net
62
53
52
Inventories
112
78
106
Total Current Liabilities
83
147
241
Payables & Accruals
- -
- -
- -
ST Debt
25
79
166
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.91%
3.2%
5.8%
Free Cash Flow
-105.65%
-146%
-1,076.02%
Net Income, GAAP
-353.73%
-124.67%
-28.64%
Sales/Revenue/Turnover
11.3%
27.04%
3.35%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
748
2025
- -
- -
773
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.04
2025
- -
- -
0.03
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Nanjing Sinolife United Company Limited (3332.HK) is a China-based investment holding company principally engaged in the manufacture and sale of nutritional supplements and health food products. The company offers a range of products including Propolis Capsules, Oyster Plus Capsules, Cranberry Plus EPO Capsules, Bilberry & Lutein Capsules, Red Super Krill soft Capsules, Viralex Attack Capsules, Viralex Revive Drink, Viralex Soothe Throat Lozenges, Vira-Complex Powder, Kids Immune Chews, Kids Vision Chews, Kids Growth Chews, Gummy Candy Series, Zhongsheng Coenzyme capsules, Guishi Weisi capsules, and Green Zhi capsules; it also manufactures and sells cosmetics and skin care products, trades and retails packaged health food products under brands such as Good Health, Zhongsheng, Pannex, and Cobayer, and leases commercial and industrial properties. Nanjing Sinolife United sells its products through distribution networks, e-commerce platforms, cross-border e-commerce channels, chain pharmacies, health goods supermarkets, and tourist souvenir shops, primarily targeting consumers in mainland China, Australia, New Zealand, Vietnam, and other international markets. Founded in 1999 and headquartered at 4/F, Building 3, Qingma 3 Road, Qixia District, Nanjing, Jiangsu Province, China, the company operates around 481 employees and focuses on research, production, and sales in the nutritional supplements industry. In recent developments, the company reported a projected net profit decline for the year ended December 31, 2024, to RMB 32-38 million from RMB 52.6 million in 2023, attributed to substantial investments in brand promotion; it released interim earnings for the half-year ended June 30, 2025, and scheduled a board meeting for March 26, 2025, to review annual results.